pantoprazole has been researched along with Asystole in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These results may influence drug choice and dosing of similarly metabolized drugs and may be helpful for designing studies in similar clinical situations." | 1.72 | Targeted temperature management after cardiac arrest is associated with reduced metabolism of pantoprazole - A probe drug of CYP2C19 metabolism. ( Clodi, C; Herkner, H; Holzer, M; Jilma, B; Mueller, M; Poppe, M; Rechenmacher, M; Reiter, B; Schoergenhofer, C; Schriefl, C; Schwameis, M; Sunder-Plaßmann, R; van Hasselt, JGC; van Os, W; Weiser, C, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poppe, M | 1 |
| Clodi, C | 1 |
| Schriefl, C | 1 |
| Mueller, M | 1 |
| Sunder-Plaßmann, R | 1 |
| Reiter, B | 1 |
| Rechenmacher, M | 1 |
| van Os, W | 1 |
| van Hasselt, JGC | 1 |
| Holzer, M | 1 |
| Herkner, H | 1 |
| Schwameis, M | 1 |
| Jilma, B | 1 |
| Schoergenhofer, C | 1 |
| Weiser, C | 1 |
| Dohr, J | 1 |
| Hunzelmann, N | 1 |
| Brown, A | 1 |
2 other studies available for pantoprazole and Asystole
| Article | Year |
|---|---|
Targeted temperature management after cardiac arrest is associated with reduced metabolism of pantoprazole - A probe drug of CYP2C19 metabolism.
Topics: Area Under Curve; Cytochrome P-450 CYP2C19; Female; Half-Life; Heart Arrest; Humans; Hypothermia, In | 2022 |
[Immediate type reactions to proton pump inhibitors using pantoprazole and omeprazole as examples].
Topics: Administration, Oral; Anaphylaxis; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Female; H | 2018 |